의원 가감지급사업 실시 전후에 따른 급성호흡기계질환의 의약품 처방특성 -국민건강보험 빅데이터를 활용하여-
Prescription Characteristics of Medication for Acute Respiratory Diseases before and after Pay-for-Performance -using National Health Insurance Big data-
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: This study analyzed the prescription characteristics of medication for acute respiratory diseases before and after pay-for-performance to provide basic data on effective medical quality management policies. Methods: The research data were collected from the 2013-2014 sample cohort of the National Health Insurance Corporation, from Internal Medicine, Pediatrics, Otorhinolaryngology, Family Medicine and General practitioner clinics (classification of disease codes: J00-J06, J20-J22, J40 outpatients). Results: The antibiotics prescription rates decreased from 43.9% in 2013 to 43.5% in 2014 when the major diagnosis was for upper respiratory infections and increased from 62.0% in 2013 to 62.5% in 2014 when the major diagnosis was for lower respiratory infections. Conclusions: There is a need to identify the correct antibiotic prescription method by expanding the current assessment standards. Such standards must include acute lower respiratory infections and minor diagnoses as the current evaluation techniques focus only on the major diagnosis of acute upper respiratory infections.
Abstract
Objectives: This study analyzed the prescription characteristics of medication for acute respiratory diseases before and after pay-for-performance to provide basic data on effective medical quality management policies. Methods: The research data were collected from the 2013-2014 sample cohort of the National Health Insurance Corporation, from Internal Medicine, Pediatrics, Otorhinolaryngology, Family Medicine and General practitioner clinics (classification of disease codes: J00-J06, J20-J22, J40 outpatients). Results: The antibiotics prescription rates decreased from 43.9% in 2013 to 43.5% in 2014 when the major diagnosis was for upper respiratory infections and increased from 62.0% in 2013 to 62.5% in 2014 when the major diagnosis was for lower respiratory infections. Conclusions: There is a need to identify the correct antibiotic prescription method by expanding the current assessment standards. Such standards must include acute lower respiratory infections and minor diagnoses as the current evaluation techniques focus only on the major diagnosis of acute upper respiratory infections.
참고문헌 (20)
- Disease Control Priorities in Developing Countries, "D. T. Jamison", World Bank, 1~27 (2006)
- Analysis of Pathogens in Acute Respiratory Infections, "KCDC", KCDC, 1~8 (2014)
- Disease Centered Pathogen Surveillance Project-Acute Respiratory Infection(ARI Net), "KCDC", KCDC, ~, pp.KCDC;3(6) (2013)
- Evaluation Project on Appropriate Prescribing Indicators Assessment Result Report 2018, "Health Insurance Review & Assessment Service", HIRA, 1~, pp.HIRA Assessment 4 (2018)
- 김수경, "급성상기도감염 항생제 처방률 공개 효과 분석", 한국임상약학회지, 20(3), pp.242~247 (2010), 한국임상약학회
- A Study on Theoretical Basis and Conceptual Framework for Maximizing the Policy Utilization, "W. Kim", HIRA, 1~85, pp.2014(57) (2014)
- Evaluation Project on Appropriate Prescribing Indicators Assessment Result Report 2014 Second half, "Health Insurance Review & Assessment Service", HIRA, 1~43, pp.HIRA Assessment 4 (2015)
- "OECD Health Statistics 2016" (2016)[URL]
- 강혜경, "급성 상기도 감염에서 항생제 처방개선에 관한 연구", 한국임상약학회지, 22(1), pp.47~54 (2012), 한국임상약학회
- 김동숙, "외래 호흡기계 질환에서 항생제 사용에 대한 후향적 평가방안", 한국임상약학회지, 22(4), pp.291~303 (2012), 한국임상약학회
- 채수미, "외래 급성 상기도 감염에서의 항생제 사용량 및 약품비 추계", 약 학 회 지, 57(3), pp.199~204 (2013), 대한약학회
- 김예지, "소아 호흡기감염 외래환자에 대한 항생제 처방양상", 보건행정학회지, 25(4), pp.323~333 (2015), 한국보건행정학회
- 최원정, "급성상기도감염 환자의 항생제 처방에 영향을 주는 요인", 보건행정학회지, 25(4), pp.256~263 (2015), 한국보건행정학회
- KOSIS, "Analysis of Main Characteristics and Changes by Life Cycle", KOSIS, 4~ (2013)
- 공미진, "1차 의료기관의 급성 상기도 감염 질환자 의약품 처방특성 - 가정의학과, 내과, 소아청소년과, 이비인후과, 일반의 중심으로 -", 보건의료산업학회지, 11(3), pp.37~49 (2017), 보건의료산업학회
- Evaluation Project on Appropriate Prescribing Indicators Assessment Result Report 2014 First half, "Health Insurance Review & Assessment Service", HIRA, 3~36, pp.HIRA Assessment 4 (2014)
- Outpatient Drug Adequacy Evaluation Model Improvement Study, "J. A. Kim", HIRA, 1~257, pp.2017(136) (2017)
- S. H. Jang, "Analysis of Factors Affecting the Injections Prescription", Department of Health Policy and Hospital Management, pp.2016